birelentinib
Generic: Birelentinib
birelentinib: 1 clinical trial tracked.
birelentinib evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about birelentinib, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
A Phase 2 Study of DZD8586 Combination Therapy in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL)
Primary endpoint: Part A: Incidence of Adverse Events
Interventionalopen66 targetStarted 2025-09Completion 2030-0115 sites · ChinaDizal (Jiangsu) Pharmaceutical Co., Ltd.